Skip to content
PICO Portalanswers from OpenAlex

Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion

PaperCitations, authors & open-access status

Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion is a paper indexed in PICO Portal from OpenAlex.

How many citations does Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion have?

PICO Portalcitation count

Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion has 371 citations in the OpenAlex counts PICO Portal stores.

When was Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion published?

PICO Portalyear

Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion has 2002 year in the PICO Portal index.

What is the open-access status of Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion?

PICO Portaloa status

Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion has bronze oa status in the PICO Portal index.

What is the DOI of Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion?

PICO Portaldoi

The DOI for Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion is on the source record.

What is the PMID of Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion?

PICO Portalpmid

The PMID for Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion is on the source record.

What is the OpenAlex record for Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion?

PICO Portalopenalex

The OpenAlex for Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial